Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsA yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.
A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.
The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.
1.
Having a tattoo could increase your risk of developing lymphoma.
2.
Knowing about and avoiding bladder cancer.
3.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
4.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
5.
Capivasertib Wins Metastatic Prostate Cancer Approval
1.
Altered Bone-Marrow Microenvironment Dynamics During Ineffective Hematopoiesis
2.
AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency
3.
Transformative Methods in Hematology for Better Care
4.
Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment
5.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Blood Clotting Disorders Explained
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Diagnosis and Management in Hematology
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation